EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Thyroid Cancer—The Tumor Immune Microenvironment (TIME) over Time and Space

Juan Carlos Jaume iD

Cancers · 26.02.2025 · 17 (5) · 794

DOI: 10.3390/cancers17050794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.02.2025. Verfasst von Juan Carlos Jaume. Beteiligte Einrichtung: Department of Medicine, Edward Hines Jr. VA Hospital Hines, Hines, IL 60141, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In thyroid cancer, the tumor immune microenvironment (TIME) plays a crucial role in cancer development, progression and response to treatment. Like many other cancers, thyroid cancer creates a complex network of interactions with immune cells directly (cell-to-cell) and via humoral mediators (i.e., cytokines). This dynamic microenvironment undergoes constant modification, which can lead to changes in the immunophenotype that might explain cancer progression, dedifferentiation and resistance to treatment. According to the cancer immunoediting hypothesis, cancerous tumors can shape their immune microenvironment to create an immunosuppressive milieu that allows them to evade classic immune surveillance. One mechanism by which this occurs is through the reprogramming of immune cells, often shifting their phenotypes from cytotoxic to regulatory. Recent research has shed light on cellular components and molecular interactions within the thyroid cancer TIME. Immune cells such as Tumor-Associated Lymphocytes (TALs), myeloid-derived suppressor cells (MDSCs), Tumor-Associated Macrophages (TAMs) and Double-Negative (DN) T cells seem to play key roles in shaping the immune response to thyroid cancer. Additionally, cytokines, chemokines and other signaling molecules contribute to the communication and regulation of immune cells within that microenvironment. By studying these interactions, researchers aim to uncover not just potential therapeutic targets but also biomarkers of thyroid cancer that could provide clues on severity and progression. Based on that knowledge, strategies such as the use of immune checkpoint inhibitors, antigen-specific targeted immunotherapies, and immunomodulatory agents are being explored to enhance the anti-tumor immune response and overcome cancer immunosuppressive mechanisms. In this review, we analyze the available literature and provide our own experience to unravel the complexity of the thyroid immune microenvironment. Continued research in this area holds promise for improving outcomes through the identification of immune markers of severity/progression of thyroid cancer and the development of innovative immunotherapeutic approaches.

Schlagwörter

Stichwörter der Autor:innen

doble negative T cells (DN T cells)myeloid-derived suppressor cells (MDSCs)thyroid cancertumor immune microenvironment (TIME)tumor-associated lymphocytes (TALs)tumor-associated macrophages

Autor:innen und Institutionen

  • Department of Medicine, Edward Hines Jr. VA Hospital Hines, Hines, IL 60141, USA.
  • Department of Medicine, Loyola University Chicago, Chicago, IL 60660, USA.

ORCID-Profile: Juan Carlos Jaume

Förderung

  • Department of Veterans Affairs

Zitieren

APA

Jaume, J. C. (2025). Thyroid Cancer—The Tumor Immune Microenvironment (TIME) over Time and Space. Cancers, 17(5), 794. https://doi.org/10.3390/cancers17050794

Vancouver

Jaume JC. Thyroid Cancer—The Tumor Immune Microenvironment (TIME) over Time and Space. Cancers. 2025;17(5):794. doi:10.3390/cancers17050794

BibTeX
@article{Jaume2025,
  author = {Jaume, Juan Carlos},
  title = {Thyroid Cancer—The Tumor Immune Microenvironment (TIME) over Time and Space},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {794},
  doi = {10.3390/cancers17050794}
}
Kostenlos starten →